Brief: Moberg Pharma Q3 EBITDA SEK -5.6 Million
Nov 11 (Reuters) - Moberg Pharma Q3 net income SEK -4.3 million. Q3 EBIT SEK -6 million Q3 EPS SEK -0.09
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains